Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

Abstract

Eight out of nine patients who received daptomycin for at least 8 days were successfully treated with the agent for Gram-positive bone and joint infections. Daptomycin was found to be well tolerated, even up to 44 days of treatment.